Literature DB >> 19457674

Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols.

Wei Jia1, Yajing Liu, Wei Li, Yan Liu, Dajun Zhang, Peng Zhang, Ping Gong.   

Abstract

A series of novel 6H-[1]benzothiopyrano[4,3-b]quinoline derivatives were prepared and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in human hepatoblastoma-derived liver Hep-G2 cells. Compounds 10g, 10h, 10j, 10l and 10o were found to be potent anti-HBV compounds with IC(50) values less than 50 microM. The most promising compound was 10l, with an IC(50) value of 14.7 microM and a SI value of 12.4. This is the first report of the anti-HBV effects of 6H-[1]benzothiopyrano[4,3-b] quinolin-9-ols.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457674     DOI: 10.1016/j.bmc.2009.05.001

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

Review 1.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

2.  Virtual screening of natural inhibitors to the predicted HBx protein structure of Hepatitis B Virus using molecular docking for identification of potential lead molecules for liver cancer.

Authors:  Rajesh Kumar Pathak; Mamta Baunthiyal; Gohar Taj; Anil Kumar
Journal:  Bioinformation       Date:  2014-07-22

Review 3.  Recent advances in the chemistry of 2-chloroquinoline-3-carbaldehyde and related analogs.

Authors:  Wafaa S Hamama; Mona E Ibrahim; Ayaa A Gooda; Hanafi H Zoorob
Journal:  RSC Adv       Date:  2018-02-23       Impact factor: 4.036

4.  Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety.

Authors:  Murat Bingul; Owen Tan; Christopher R Gardner; Selina K Sutton; Greg M Arndt; Glenn M Marshall; Belamy B Cheung; Naresh Kumar; David StC Black
Journal:  Molecules       Date:  2016-07-14       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.